The receptor question, in one paragraph The primary pharmacological differences between these peptides arise from the receptor they activate, although molecular structure and pharmacokinetic properties also contribute
This function is defective in type 2 diabetes [7,8,9], presumably because DPP-4 activity is enhanced in patients with glucose intolerance [9,10,11]
After 68 weeks, half of the participants taking Semaglutide GLP-1 had lost 15 percent of their body weight, and nearly a third had lost 20 percent
At 2.5 mg/mL, 20 units puts you at 0.5 mg, the week 5-8 dose
Most patients dont know they have a hiatal hernia, most are diagnosed incidentally during X-rays or endoscopies for other reasons